flurbiprofen has been researched along with Alloxan Diabetes in 6 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flurbiprofen treatment of ND rats replicated many of the biochemical and physiological abnormalities of EDN, i." | 1.31 | Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. ( Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C, 2002) |
| "Flurbiprofen co-treatment markedly attenuated these actions of pentoxifylline on nerve conduction and blood flow whereas NG-nitro-L-arginine was without effect." | 1.31 | Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats. ( Cameron, NE; Cotter, MA; Flint, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pop-Busui, R | 1 |
| Marinescu, V | 1 |
| Van Huysen, C | 1 |
| Li, F | 1 |
| Sullivan, K | 1 |
| Greene, DA | 1 |
| Larkin, D | 1 |
| Stevens, MJ | 1 |
| Dines, KC | 3 |
| Cameron, NE | 5 |
| Cotter, MA | 5 |
| Maxfield, EK | 1 |
| Robertson, S | 1 |
| Cox, D | 1 |
| Hohman, TC | 1 |
| Flint, H | 1 |
6 other studies available for flurbiprofen and Alloxan Diabetes
| Article | Year |
|---|---|
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase | 2002 |
Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Dietary Fats, Unsaturated; Dose-Response Relationship, Dru | 1995 |
Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
Topics: Animals; Arginine; Capillaries; Cell Hypoxia; Diabetes Mellitus, Experimental; Diabetic Neuropathies | 1993 |
The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
Topics: Action Potentials; Animals; Body Weight; Capillaries; Cyclooxygenase Inhibitors; Diabetes Mellitus, | 1993 |
Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
Topics: Acetanilides; Aldehyde Reductase; Analysis of Variance; Animals; Arginine; Blood Glucose; Body Weigh | 1996 |
Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats.
Topics: Animals; Blood Glucose; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Flurbiprofen; Ma | 2000 |